FDA Policy for REMS Reqmts during COVID-19
Health Care, Pharma Industry, Strategic Planning
FDA is issuing this guidance to communicate its temporary policy for certain risk evaluation and mitigation strategies (REMS) requirements for the duration of the coronavirus pandemic public health emergency.
Read the Policy now
Related Education Resources.
All ResourcesForecasting
Topics: EAP, Forecasting / Planning
Video
Members
Understanding Blockchain and AI in the Clinical Supply Chain
Topics: Conference, Supply Chain
Video
Members
Expanded Access: Past, Present and Future Improvements
Topics: Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning
Position Paper
Free
